Literature DB >> 17174647

Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy.

Evan C Adelstein1, Samir Saba.   

Abstract

BACKGROUND: About 30% of patients with heart failure do not respond to cardiac resynchronization therapy (CRT). We hypothesized that scar burden can predict poor response to CRT in patients with ischemic cardiomyopathy (ICM).
METHODS: Fifty patients (age, 68.5 +/- 9.2 years; 84% men; mean left ventricular ejection fraction (LVEF), 19.7% +/- 5.2%) with ICM who underwent CRT-defibrillator implantation and 201Tl single photon emission computed tomography myocardial perfusion imaging were included. Myocardial perfusion imaging studies were read quantitatively, generating a summed perfusion score (SPS). Left ventricular (LV) lead position was determined by chest radiography. Echocardiograms were performed before and after (median, 11.0 months) CRT.
RESULTS: Echocardiographic response, defined as > or = 15% relative increase in LVEF, was documented in 28 (56%) patients. The mean SPS (18.8 +/- 11.3 vs 33.7 +/- 11.1; P = .000025) and the average scar density in the segments immediately adjacent to the LV lead (0.70 +/- 0.91 vs 1.64 +/- 0.82; P = .0004) were significantly lower in responders versus nonresponders. Global scar burden (r = -0.53; P = .00007), scar burden near the LV lead (r = -0.49; P = .0003), and the number of segments with a score of 4 (r = -0.53; P = .0007) inversely correlated with increase in LVEF after CRT. The hazard ratio for nonresponse increased with increasing tertiles of global SPS, scar density in the vicinity of the LV lead, and number of segments with transmural scar (ie, perfusion score = 4).
CONCLUSIONS: Higher overall scar burden, a larger number of severely scarred segments, and greater scar density near the LV lead tip portend an unfavorable response to CRT in ICM patients. Prospective confirmation of these findings is warranted.

Entities:  

Mesh:

Year:  2007        PMID: 17174647     DOI: 10.1016/j.ahj.2006.10.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  63 in total

Review 1.  Nuclear Image-Guided Approaches for Cardiac Resynchronization Therapy (CRT).

Authors:  Weihua Zhou; Ernest V Garcia
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

2.  QRS fragmentation is not associated with poor response to cardiac resynchronization therapy.

Authors:  John Rickard; Omeed Zardkoohi; Zoran Popovic; David Verhaert; Dan Sraow; Bryan Baranowski; David O Martin; Richard A Grimm; Mina K Chung; Patrick Tchou; Bruce A Lindsay; Bruce L Wilkoff
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

3.  Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.

Authors:  Evan C Adelstein; Hidekazu Tanaka; Prem Soman; Glen Miske; Stephanie C Haberman; Samir F Saba; John Gorcsan
Journal:  Eur Heart J       Date:  2010-10-22       Impact factor: 29.983

4.  Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy.

Authors:  John Gorcsan; Olusegun Oyenuga; Phillip J Habib; Hidekazu Tanaka; Evan C Adelstein; Hideyuki Hara; Dennis M McNamara; Samir Saba
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

5.  Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study.

Authors:  Michael V Orlov; Michael Maysky; Spyridon T Akrivakis; Michael R Ujhelyi; Peter Hoffmeister; Gunjan Shukla; Susan McAllister; Gregory Kotler; Ibrahim Almasry; G Muqtada Chaudhry; Charles I Haffajee
Journal:  J Interv Card Electrophysiol       Date:  2008-08-07       Impact factor: 1.900

Review 6.  Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes.

Authors:  Jeffrey Liu; Evan Adelstein; Samir Saba
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

7.  The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET.

Authors:  Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-01       Impact factor: 9.236

Review 8.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

9.  Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy.

Authors:  Chiara Cavallino; Elisa Rondano; Andrea Magnani; Lucia Leva; Eugenio Inglese; Gabriele Dell'era; Eraldo Occhetta; Miriam Bortnik; Paolo N Marino
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-19       Impact factor: 2.357

10.  Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.

Authors:  Allen E Atchley; Dalane W Kitzman; David J Whellan; Ami E Iskandrian; Stephen J Ellis; Robert A Pagnanelli; Andrew Kao; Khaled Abdul-Nour; Christopher M O'Connor; Greg Ewald; William E Kraus; Salvador Borges-Neto
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.